A US-based KOL provides insights into treatment and diagnosis rates, prescribing habits, key marketed brands and late-phase therapies for ADHD. Particular attention is paid to the differences in treatment strategies between pediatric patients and adults. 

This interview was conducted on Nov. 2, 2023. 

If you are a KOL Insight subscriber, you may also access the interview from our KOL Insight portal.

Biomedtracker’s KOL Insight transcripts are available through subscription only. For more information on obtaining a KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (888) 670-8900. 

For our disclosures, please read the Biomedtracker Research Standards.